April 18, 2005

Penn Researchers Determine Structure of Binding Site of Colon-Cancer Drug and Its Protein Target
Finding Will Steer Future Treatment Design

Schematic showing how Erbitux takes the place of the EGFR growth factor, thereby inhibiting cancerous growth.

Image courtesy of Kate Ferguson and Cancer Cell.